SG11201503765XA - METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF - Google Patents

METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF

Info

Publication number
SG11201503765XA
SG11201503765XA SG11201503765XA SG11201503765XA SG11201503765XA SG 11201503765X A SG11201503765X A SG 11201503765XA SG 11201503765X A SG11201503765X A SG 11201503765XA SG 11201503765X A SG11201503765X A SG 11201503765XA SG 11201503765X A SG11201503765X A SG 11201503765XA
Authority
SG
Singapore
Prior art keywords
forms
oxidopyridyn
cristal
cyclopropylmethoxy
methoxypyridine
Prior art date
Application number
SG11201503765XA
Inventor
Pascal Billot
Didier Brige
Alexandre Giuliani
Hagit Elmaleh
Marc-Antoine Perrin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG11201503765XA publication Critical patent/SG11201503765XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201503765XA 2012-11-28 2013-11-28 METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF SG11201503765XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306479 2012-11-28
PCT/EP2013/074972 WO2014083107A1 (en) 2012-11-28 2013-11-28 METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF

Publications (1)

Publication Number Publication Date
SG11201503765XA true SG11201503765XA (en) 2015-06-29

Family

ID=47324005

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503765XA SG11201503765XA (en) 2012-11-28 2013-11-28 METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF

Country Status (13)

Country Link
US (1) US9533953B2 (en)
EP (1) EP2935219A1 (en)
JP (1) JP2016500094A (en)
KR (1) KR20150087252A (en)
CN (1) CN104955808A (en)
AU (1) AU2013351146A1 (en)
BR (1) BR112015011849A2 (en)
CA (1) CA2892156A1 (en)
IL (1) IL238828A0 (en)
MX (1) MX2015006807A (en)
RU (1) RU2621894C2 (en)
SG (1) SG11201503765XA (en)
WO (1) WO2014083107A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711282B1 (en) * 1993-07-28 2002-06-05 Aventis Pharma Limited Compounds as pde iv and tnf inhibitors
US20060004056A1 (en) * 2002-07-02 2006-01-05 Bernard Cote Di-aryl-substituted-ethan pyridone pde4 inhibitors
FR2915099B1 (en) * 2007-04-19 2009-06-05 Sanofi Aventis Sa USE OF 4-CYCLOPROPYLMETHOXY-N- (3,5-DICHLORO-1-OXYDO-PYRIDIN-4-YL) -5- (METHOXY) PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF CRANIAL TRAUMATISM
FR2915098B1 (en) * 2007-04-19 2009-06-05 Sanofi Aventis Sa USE OF 4-CYCLOPROPYLMETHOXY-N- (3,5-DICHLORO-1-OXYDO-PYRIDIN-4-YL) -5- (METHOXY) PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF TRAUMATISMS OF SPINAL CORD
FR2915100B1 (en) * 2007-04-19 2009-06-05 Sanofi Aventis Sa USE OF 4-CYCLOPROPYLMETHOXY-N- (3,5-DICHLORO-1-OXYDO-PYRIDIN-4-YL) -5- (METHOXY) PYRIDINE-2-CARBOXALIDE FOR THE TREATMENT OF PARKINSON'S DISEASE-RELATED MOTOR DISORDERS

Also Published As

Publication number Publication date
MX2015006807A (en) 2016-01-14
EP2935219A1 (en) 2015-10-28
JP2016500094A (en) 2016-01-07
WO2014083107A1 (en) 2014-06-05
RU2015125304A (en) 2017-01-11
IL238828A0 (en) 2015-06-30
US9533953B2 (en) 2017-01-03
CA2892156A1 (en) 2014-06-05
AU2013351146A1 (en) 2015-06-11
KR20150087252A (en) 2015-07-29
US20150322014A1 (en) 2015-11-12
BR112015011849A2 (en) 2017-07-11
RU2621894C2 (en) 2017-06-08
CN104955808A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
HK1209736A1 (en) N-substituted benzamides and methods of use thereof n-
HK1223913A1 (en) Substituted benzamides and methods of use thereof
HK1205938A1 (en) Inhibitors of human ezh2, and methods of use thereof ezh2
EP2831195A4 (en) Microemulsion flowback aid composition and method of using same
EP2573070A4 (en) Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof
EP2808318A4 (en) Crystal form of prostaglandin analogue, and preparation method and use thereof
ZA201406145B (en) Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
HRP20181704T1 (en) Crystal form of chidamide, preparation method and use thereof
EP2803657A4 (en) Crystal form of prostaglandin analogue, and preparation method and use thereof
EP2744422A4 (en) Suture passing instrumentation and methods of use thereof
EP2672820A4 (en) Mannoside compounds and methods of use thereof
EP2835369A4 (en) Crystal form of cabazitaxel and preparation method thereof
EP2938341A4 (en) Heterocyclic compounds and methods of use thereof
EP2834421A4 (en) Stabilizing agents and methods of use thereof
PL2814463T3 (en) Ophthalmic pharmaceutical compositions and methods of making and using same
HK1193087A1 (en) New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same vii
IL234492A (en) Crystal forms of 5α-androstane-3β,5,6β-triol and preparation methods therefor
EP2844219A4 (en) Sensitization composition and method of use
HK1210143A1 (en) Crystal forms of azetidinone compounds and preparing methods thereof
IL238828A0 (en) Method of preparation of crystal forms of 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxidopyridyn-4-yl)-5-methoxyridine-2-carboxamide and cristal forms thereof
GB201223374D0 (en) Personal care composition and methods of making the same
AU2013901754A0 (en) Fabric care composition and method of use thereof
IL238829A0 (en) Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide